scholarly journals Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy

2015 ◽  
Vol 93 (8) ◽  
pp. 762-766 ◽  
Author(s):  
Cecilia Rönnbäck ◽  
Claus Nissen ◽  
Gitte J. Almind ◽  
Karen Grønskov ◽  
Dan Milea ◽  
...  
Cell Calcium ◽  
2015 ◽  
Vol 57 (1) ◽  
pp. 49-55 ◽  
Author(s):  
László Fülöp ◽  
Anikó Rajki ◽  
Erika Maka ◽  
Mária Judit Molnár ◽  
András Spät

2012 ◽  
Vol 68 (2) ◽  
pp. 108-110 ◽  
Author(s):  
X. Ayrignac ◽  
C. Liauzun ◽  
G. Lenaers ◽  
D. Renard ◽  
P. Amati-Bonneau ◽  
...  

Author(s):  
Christoph Jüschke ◽  
Thomas Klopstock ◽  
Claudia B. Catarino ◽  
Marta Owczarek-Lipska ◽  
Bernd Wissinger ◽  
...  

Brain ◽  
2006 ◽  
Vol 130 (4) ◽  
pp. 1029-1042 ◽  
Author(s):  
M. V. Alavi ◽  
S. Bette ◽  
S. Schimpf ◽  
F. Schuettauf ◽  
U. Schraermeyer ◽  
...  

2019 ◽  
pp. 29-34
Author(s):  
Matthew J. Thurtell ◽  
Robert L. Tomsak

There is a broad differential diagnosis for bilateral optic neuropathies, including inflammatory, ischemic, compressive, traumatic, nutritional, toxic, and inherited causes. In this chapter, we begin by discussing the approach to the patient who has bilateral symmetric optic neuropathies. We next review the genetic basis, clinical features, and natural history of autosomal dominant optic atrophy. We list other deficits that can occur in up to 20% of patients with this condition, which can include sensorineural hearing loss, ataxia, myopathy, peripheral neuropathy, spastic paraparesis, and chronic progressive external ophthalmoplegia. Lastly, we discuss the evaluation and management approach for autosomal dominant optic atrophy.


Sign in / Sign up

Export Citation Format

Share Document